# Aura Biosciences, Inc.: Form SCHEDULE 13D/A, filed May 11, 2026

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-11
- Accepted by EDGAR: May 11, 2026, 16:15 ET
- Period: not reported
- Accession: 0000950142-26-001345
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000095014226001345/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000095014226001345/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000095014226001345/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 11, 2026.
Source: SEC EDGAR, the filing index for accession 0000950142-26-001345. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.